CSIMarket
 
Syros Pharmaceuticals Inc   (SYRS)
Other Ticker:  
 
 

Syros Pharmaceuticals Inc Income Statement Quarterly

SYRS


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Revenue From Contract With Customer Excluding Assessed Tax 3.76 2.83 2.95 3.89
Total Revenue 3.76 2.83 2.95 -0.75 3.89
Cost of Revenues - - - - -
Gross Profit 3.76 2.83 2.95 -0.75 3.89
Selling, Administration, Marketing 7.76 7.23 7.41 7.33 8.08
Depriciation & Amortization - - - - -
Research and Development Expense 28.28 29.61 28.76 27.91 25.76
Restructuring Charges 2.35 - - - -
Other operatinig exp. /-income - - 0.00 - 9.51
Unusual Expense /-Income - - - - -
Total operating costs including COS 38.40 36.83 36.17 35.24 43.35
Operating income/-loss -34.64 -34.00 -33.21 -36.00 -39.45
Other Deductions / - Income
Interest expense 1.30 1.28 1.22 3.09 1.05
Interest income - - - - -
Net interest expense/-income 1.30 1.28 1.22 - 1.05
Investment Income, Interest - - - - -
Foreign Currency Transaction (Gain) Loss - - - - -
Allowances, Health Care Trust Fund And Other - - - - -
Unexpected (Gain) Loss - - - - -
Other loss/ -income -1.63 -2.13 -10.64 -31.22 -10.25
Fair Value Adjustment Of Warrants 5.84 3.11 - - -
Total costs & expenses 43.91 39.09 26.74 4.02 34.14
Income /-loss before income taxes -40.14 -36.26 -23.79 -4.77 -30.25
Income taxes expenses/-benefit - - - - -
Income after income taxes -40.14 -36.26 -23.79 -4.77 -30.25
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. -40.14 -36.26 -23.79 -4.77 -30.25
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss -40.14 -36.26 -23.79 -4.77 -30.25
Noncontrolling interests - - - - -
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder -40.14 -36.26 -23.79 -4.77 -30.25
EBIT -38.84 -34.98 -22.57 -4.77 -29.20
EBITD -38.23 -34.33 -21.93 -4.07 -28.54
EBITDA -38.23 -34.33 -21.93 -4.07 -28.54


Per Share (GAAP Quarterly, in $) (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Basic EPS (excl. extra items) -1.43 -1.30 -0.85 -0.38 -3.21
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS -1.43 -1.30 -0.85 -0.38 -3.21
Basic shares outstanding (Mill. of Units) 27.99 27.91 27.84 63.82 9.42
   EPS other shares - - - - -
Diluted Net EPS -1.43 -1.30 -0.85 -0.38 -3.21
Diluted average shares (Mill. of Units) 27.99 27.91 27.84 63.82 9.42
Dividend per share - - - - -



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com